Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.04 | 0.0387 | 0.0387 |
Schistosoma mansoni | subfamily A22A unassigned peptidase (A22 family) | 0.097 | 0.489 | 1 |
Echinococcus multilocularis | synaptic glycoprotein sc2 | 0.0467 | 0.0912 | 0.1866 |
Trypanosoma brucei | 3-oxo-5-alpha-steroid 4-dehydrogenase-like, putative | 0.1618 | 1 | 1 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1618 | 1 | 1 |
Echinococcus multilocularis | 3 oxo 5 alpha steroid 4 dehydrogenase, C terminal | 0.0467 | 0.0912 | 0.1866 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1618 | 1 | 1 |
Leishmania major | presenilin-like aspartic peptidase, putative,presenilin-like aspartic peptidase, clan AD, family A22A, putative | 0.097 | 0.489 | 0.1541 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0467 | 0.0912 | 0.1866 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.097 | 0.489 | 0.489 |
Brugia malayi | Presenilin family protein | 0.097 | 0.489 | 0.489 |
Onchocerca volvulus | 0.0467 | 0.0912 | 0.5 | |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0467 | 0.0912 | 0.0912 |
Plasmodium vivax | polyprenol reductase, putative | 0.0467 | 0.0912 | 0.5 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0852 | 0.396 | 0.3353 |
Giardia lamblia | Synaptic glycoprotein SC2 | 0.0467 | 0.0912 | 1 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0467 | 0.0912 | 0.0912 |
Trypanosoma cruzi | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.0852 | 0.396 | 0.3353 |
Trypanosoma brucei | 3-hydroxy-3-methylglutaryl-CoA reductase, putative | 0.0852 | 0.396 | 0.3353 |
Trypanosoma cruzi | presenilin-like aspartic peptidase, putative | 0.097 | 0.489 | 0.4377 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1618 | 1 | 1 |
Echinococcus multilocularis | presenilin | 0.097 | 0.489 | 1 |
Plasmodium falciparum | polyprenol reductase, putative | 0.0467 | 0.0912 | 0.5 |
Schistosoma mansoni | synaptic glycoprotein sc2 related | 0.0467 | 0.0912 | 0.1866 |
Loa Loa (eye worm) | hypothetical protein | 0.0467 | 0.0912 | 0.0912 |
Echinococcus granulosus | presenilin | 0.097 | 0.489 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0852 | 0.396 | 0.396 |
Plasmodium vivax | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0467 | 0.0912 | 0.5 |
Trichomonas vaginalis | synaptic glycoprotein sc2, putative | 0.0467 | 0.0912 | 0.0912 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.097 | 0.489 | 0.489 |
Trichomonas vaginalis | Clan AD, family A22, presenilin-like aspartic peptidase | 0.097 | 0.489 | 0.489 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0467 | 0.0912 | 0.0912 |
Plasmodium falciparum | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0467 | 0.0912 | 0.5 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1618 | 1 | 1 |
Schistosoma mansoni | hydroxymethylglutaryl-CoA reductase (NADPH) | 0.0852 | 0.396 | 0.8097 |
Loa Loa (eye worm) | hypothetical protein | 0.1618 | 1 | 1 |
Trichomonas vaginalis | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.0467 | 0.0912 | 0.0912 |
Mycobacterium ulcerans | hypothetical protein | 0.1618 | 1 | 1 |
Brugia malayi | Synaptic glycoprotein SC2 | 0.0467 | 0.0912 | 0.0912 |
Toxoplasma gondii | 3-oxo-5-alpha-steroid 4-dehydrogenase | 0.1618 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0467 | 0.0912 | 0.0912 |
Loa Loa (eye worm) | hypothetical protein | 0.0467 | 0.0912 | 0.0912 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.04 | 0.0387 | 0.0387 |
Entamoeba histolytica | presenilin 1 peptidase, putative | 0.097 | 0.489 | 0.4377 |
Trypanosoma cruzi | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative | 0.1618 | 1 | 1 |
Trypanosoma brucei | presenilin-like aspartic peptidase, putative | 0.097 | 0.489 | 0.4377 |
Leishmania major | 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein | 0.1618 | 1 | 1 |
Echinococcus multilocularis | hydroxymethylglutaryl coenzyme A reductase | 0.0852 | 0.396 | 0.8097 |
Echinococcus granulosus | 3 oxo 5 alpha steroid 4 dehydrogenase C terminal | 0.0467 | 0.0912 | 0.1866 |
Entamoeba histolytica | steroid 5-alpha reductase, putative | 0.1618 | 1 | 1 |
Brugia malayi | Hydroxymethylglutaryl-coenzyme A reductase family protein | 0.0852 | 0.396 | 0.396 |
Trypanosoma cruzi | presenilin-like aspartic peptidase, putative | 0.097 | 0.489 | 0.4377 |
Echinococcus granulosus | hydroxymethylglutaryl coenzyme A reductase | 0.0852 | 0.396 | 0.8097 |
Echinococcus granulosus | synaptic glycoprotein sc2 | 0.0467 | 0.0912 | 0.1866 |
Trichomonas vaginalis | 3-hydroxy-3-methylglutaryl-coenzyme A reductase, putative | 0.04 | 0.0387 | 0.0387 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 1 mg kg-1 | Prokinetic activity expressed as stimulation of intragastric pressure in rat at the lowest active dose in mg/kg on subcutaneous administration. | ChEMBL. | No reference |
ED50 (functional) | = 38 mg kg-1 | Dopamine antagonist activity expressed as inhibition of apomorphine-induced climbing in mice, subcutaneous administration | ChEMBL. | No reference |
ED50 (functional) | = 38 mg kg-1 | Dopamine antagonist activity expressed as inhibition of apomorphine-induced climbing in mice, subcutaneous administration | ChEMBL. | No reference |
ED50 (functional) | > 50 mg kg-1 | Dopamine antagonist activity expressed as inhibition of apomorphine-induced climbing in mice, subcutaneous administration | ChEMBL. | No reference |
ED50 (functional) | > 50 mg kg-1 | Dopamine antagonist activity expressed as inhibition of apomorphine-induced climbing in mice, subcutaneous administration | ChEMBL. | No reference |
Ratio (functional) | = 38 | Selectivity at Dopamine receptors compared to 5-HT receptors. | ChEMBL. | No reference |
Ratio (functional) | > 50 | Selectivity at Dopamine receptors compared to 5-HT receptors. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.